首页 > 市场调查报告书 > 医疗设备

生技设备基因治疗学和RNAi

市场调查报告书

商品编码

1658185

微阵列分析市场规模、份额和成长分析（按产品、类型、应用、最终用户和地区）- 产业预测 2025-2032

Microarray Analysis Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Type (DNA Microarray, Protein Microarray), By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年02月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年微阵列分析市场规模价值 37 亿美元，预计将从 2024 年的 39.9 亿美元成长到 2032 年的 73.3 亿美元，预测期间（2025-2032 年）的复合年增长率为 7.9%。

在技术进步和个人化医疗需求日益增长的推动下，全球微阵列分析市场正在经历显着增长。这种高通量技术使得同时检查数千个基因成为可能，其驱动因素包括基因组研究的进步和慢性病的增加。主要应用包括基因表现表现谱、基因型鉴定和生物标记发现，并透过实现大规模基因研究和药物发现改变了基因组学和分子生物学研究。微阵列分析与次世代定序和生物资讯学等新技术之间的协同效应正在进一步推动市场扩张。虽然北美凭藉其强大的研究基础设施仍然是主导市场，但随着新兴经济体采用微阵列技术，亚太地区预计将经历快速成长，为个人化医疗和诊断领域的持续创新奠定市场基础。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司详细信息
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

Illumina, Inc.（United States）
Agilent Technologies, Inc.（United States）
Thermo Fisher Scientific, Inc.（United States）
Merck KGaA（Germany）
PerkinElmer, Inc.（United States）
Arrayit Corporation（United States）
Bio-Rad Laboratories, Inc.（United States）
GE Healthcare（United States）
Molecular Devices, LLC.（United States）
Affymetrix（United States）
Applied Microarrays, Inc.（United States）
Oxford Gene Technology（United Kingdom）
CapitalBio Corporation（China）
Macrogen, Inc.（South Korea）
LC Sciences（United States）
Scienion AG（Germany）
Arrayjet Ltd.（United Kingdom）
RayBiotech, Inc.（United States）
Genotypic Technology Pvt. Ltd.（India）
Microarrays Inc.（United States）

结论和建议

简介目录

Product Code: SQMIG35J2057

Microarray Analysis Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.99 billion in 2024 to USD 7.33 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The global Microarray Analysis Market is experiencing significant growth, fueled by technological advancements and the rising need for personalized medicine. This high-throughput technique allows for the simultaneous examination of thousands of genes, driven by factors like genomic research advancements and the increasing incidence of chronic diseases. Key applications include gene expression profiling, genotyping, and biomarker discovery, which have transformed genomics and molecular biology research by enabling large-scale gene studies and drug discovery. The synergy between microarray analysis and emerging technologies such as next-generation sequencing and bioinformatics further propels market expansion. While North America remains the dominant player due to robust research infrastructure, the Asia-Pacific region is set for rapid growth as emerging economies embrace microarray technologies, positioning the market for ongoing innovation in personalized medicine and diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Microarray Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Microarray Analysis Market Segments Analysis

Global Microarray Analysis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Type, the market is segmented into DNA Microarray, Protein Microarray and Others. Based on Application, the market is segmented into Rese arch Applications, Drug Discovery, Disease Diagnostics and Others Applications. Based on End User, the market is segmented into Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Microarray Analysis Market

A significant catalyst for the Global Microarray Analysis Market is the rising demand for personalized medicine. This innovative medical approach focuses on customizing treatments for individual patients by taking into account their unique genetic profiles, leading to more accurate and effective therapeutic strategies. In this context, microarray analysis is essential, as it delivers extensive genomic data and assists in pinpointing genetic variations linked to diseases. As personalized medicine continues to gain traction globally, the need for microarray analysis technology intensifies, further propelling market expansion and innovation in the field of genomics and healthcare.

Restraints in the Microarray Analysis Market

A significant limitation facing the Global Microarray Analysis Market is the substantial financial burden linked to microarray technologies and their analysis. The expense associated with microarray platforms, reagents, and instruments can render them inaccessible to numerous research institutions and healthcare facilities that operate under tight budget constraints. Furthermore, the intricate nature of data analysis, combined with the necessity for specialized knowledge, exacerbates the cost issue. This financial challenge is particularly pronounced in resource-limited contexts, stifling broader adoption and growth within the market. Addressing this restraint requires efforts aimed at cost reduction and enhancing affordability through technological innovations and optimized workflows.

Market Trends of the Microarray Analysis Market

The Global Microarray Analysis Market is currently witnessing a notable trend characterized by the integration of microarray technologies with other omics platforms, particularly next-generation sequencing (NGS) and advanced bioinformatics tools. This convergence enhances data analysis capabilities, enabling researchers to achieve a holistic view of biological systems through a detailed examination of the genome, transcriptome, and epigenome. By combining these powerful technologies, scientists can gain deeper insights into gene expression, genetic variations, and complex biological processes related to diseases and personalized medicine. This trend not only promotes innovative research methodologies but also drives the demand for integrated solutions that facilitate multi-dimensional molecular profiling, positioning microarray analysis as a vital component in the evolving landscape of genomics and biotechnology.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Microarray Analysis Market Size by Product & Services & CAGR (2025-2032)

Market Overview
Consumables
Instruments
Software
Services

Global Microarray Analysis Market Size by Type & CAGR (2025-2032)

Market Overview
DNA Microarray
Protein Microarray
Others

Global Microarray Analysis Market Size by Application & CAGR (2025-2032)

Market Overview
Research Applications
Drug Discovery
Disease Diagnostics
Others Applications

Global Microarray Analysis Market Size by End User & CAGR (2025-2032)

Market Overview
Research and Academic Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Others

Global Microarray Analysis Market Size & CAGR (2025-2032)

North America (Product & Services, Type, Application, End User)
- US
- Canada
Europe (Product & Services, Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Services, Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Services, Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Services, Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arrayit Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Devices, LLC. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Affymetrix (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Microarrays, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Gene Technology (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapitalBio Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macrogen, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LC Sciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Scienion AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arrayjet Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genotypic Technology Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microarrays Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments